Flavius Martin
6Patents
5h-index
9Co-inventors
52Inventor score
Filing activity: Dec 11, 2003 → Apr 8, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7812133B2 | Anti-OX40L antibodies and methods using same | Chemistry; Metallurgy | 29 | Active |
| US7402728B2 | Transgenic mice expressing human CD20 and/or CD16 | Human Necessities | 16 | Expired |
| US9822400B2 | Methods for treating, diagnosing, and monitoring rheumatoid arthritis | Emerging Cross-Sectional Technologies | 6 | Active |
| US8728730B2 | Methods for treating, diagnosing, and monitoring rheumatoid arthritis | Emerging Cross-Sectional Technologies | 6 | Active |
| US8617545B2 | Methods for use with BAFF antagonists | Physics | 5 | Active |
| US9726673B2 | Methods and compositions related to B cell assays | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.